Aclarion Stock Current Asset
| ACON Stock | USD 7.70 0.35 4.35% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Aclarion's long-term financial health and intrinsic value.
At this time, Aclarion's Non Current Assets Total are very stable compared to the past year. As of the 25th of September 2025, Total Current Assets is likely to grow to about 891.5 K, while Other Current Assets are likely to drop about 228.4 K. Aclarion | Current Asset | Build AI portfolio with Aclarion Stock |
Aclarion Company Current Asset Analysis
Aclarion's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Aclarion Current Asset Historical Pattern
Today, most investors in Aclarion Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aclarion's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Aclarion current asset as a starting point in their analysis.
Aclarion Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Aclarion Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Aclarion has a Current Asset of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Aclarion Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aclarion from analyzing Aclarion's financial statements. These drivers represent accounts that assess Aclarion's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aclarion's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 176.7B | 20.9M | 3.1M | 2.7M | (330.9K) | (314.3K) |
Aclarion ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aclarion's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aclarion's managers, analysts, and investors.Environmental | Governance | Social |
Aclarion Fundamentals
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.44 | ||||
| Operating Margin | (89.89) % | ||||
| Current Valuation | 4.29 M | ||||
| Shares Outstanding | 582.37 K | ||||
| Shares Owned By Institutions | 0.77 % | ||||
| Number Of Shares Shorted | 12.09 K | ||||
| Price To Book | 0.33 X | ||||
| Price To Sales | 74.48 X | ||||
| Revenue | 45.72 K | ||||
| Gross Profit | (16.6 K) | ||||
| EBITDA | (6.26 M) | ||||
| Net Income | (6.99 M) | ||||
| Cash And Equivalents | 3.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.15 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 24.37 X | ||||
| Cash Flow From Operations | (5.27 M) | ||||
| Short Ratio | 1.05 X | ||||
| Earnings Per Share | (12.12) X | ||||
| Target Price | 22.0 | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 4.69 M | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (51.26 M) | ||||
| Working Capital | (329.15 K) | ||||
| Net Asset | 2.12 M |
About Aclarion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aclarion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aclarion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aclarion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aclarion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aclarion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will appreciate offsetting losses from the drop in the long position's value.Moving against Aclarion Stock
| 0.48 | EW | Edwards Lifesciences Corp | PairCorr |
| 0.39 | EUDA | EUDA Health Holdings | PairCorr |
| 0.32 | DRIO | DarioHealth Corp Trending | PairCorr |
The ability to find closely correlated positions to Aclarion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aclarion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aclarion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aclarion to buy it.
The correlation of Aclarion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aclarion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aclarion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aclarion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aclarion Piotroski F Score and Aclarion Altman Z Score analysis. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.12) | Revenue Per Share | Quarterly Revenue Growth 0.761 | Return On Assets | Return On Equity |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.